NCT06867835View on ClinicalTrials.gov

Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

PHASE4RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Lactating Mother
Interventions
DRUG

Vyleesi (Bremelanotide Injection)

Single dose of BMT 1.75 mg SC on Day 1

Trial Locations (1)

33178

RECRUITING

First Excellence Research Group LLC, Doral

Sponsors
All Listed Sponsors
lead

Cosette Pharmaceuticals, Inc.

INDUSTRY